Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Sulkowski, Grzegorz ^a   Dąbrowska Bouta, Beata ^a   Salińska, Elzbieta ^a   Struzyńska, Lidia ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; AMANTADINE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; LY 367583; MEMANTINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; AMINO ACID RECEPTOR BLOCKING AGENT; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE RECEPTOR; SLC1A2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EXCITOTOXICITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; NERVE CELL MEMBRANE; NERVE ENDING; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SYNAPSE; ANIMAL; BRAIN; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; LEWIS RAT; METABOLISM;

RATTUS;

ANIMALS; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; FEMALE; GLUTAMIC ACID; RATS; RATS, INBRED LEW; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84913528985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113954     Document Type: Article

References (47)

1. Groom AJ, Smith T, Turski L (2003) Multiple sclerosis and glutamate. Ann N Y Acad Sci 993: 229-275.
2. Matute C, Alberdi E, Domercq M, Sánchez-Gómez MV, Pérez-Samartín A, et al. (2007) Excitotoxic damage to white matter. J Anat 210: 693-702.
3. Lassmann H (2002) Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clin Neurol Neurosurg 104: 168-171.
4. Bolton C, Paul C (2006) Glutamate receptors in neuroinflammatory demyelinating disease. Mediators Inflamm 2006: 93684.
5. Pryce G, O'Neill JK, Croxford JL, Amor S, Hankey DJ, et al. (2005) Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis. J Neuroimmunol 165: 41-52.
6. Geurts JJ, Wolswijk G, Bö L, van der Valk P, Polman CH, et al. (2003) Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 126: 1755-1766.
7. Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, et al (2001) The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24: 224-230.
8. Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, et al. (2005) Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis. Glia 51: 235-240.
9. Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50: 169-180.
10. Choi DW (1994) Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 747: 162-171.
11. Dubinsky JM, Rothman SM (1991) Intracellular calcium concentrations during 'chemical hypoxia' and excitotoxic neuronal injury. J Neurosci 11: 2545-2551.
12. Marini AM, Ueda Y, June CH (1999) Intracellular survival pathways against glutamate receptor agonist excitotoxicity in cultured neurons. Intracellular calcium responses. Ann N Y Acad Sci 890: 421-437.
13. Otis TS, Brasnjo G, Dzubay JA, Pratap M (2004) Interactions between glutamate transporters and metabotropic glutamate receptors at excitatory synapses in the cerebellar cortex. Neurochem Int 45: 537-544.
14. Danbolt N (2001) Glutamate uptake. Prog Neurobiol 65: 1-105.
15. Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6: 67-70.
16. Paul C, Bolton C (2002) Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine. J Pharmacol Exp Ther 302: 50-57.
17. Ziemińska E, Stafiej A, Łazarewicz JW (2003) Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurons. Neurochem Int 43: 481-492.
18. Slotboom DJ, Konings WN, Lolkema JS (1999) Structural features of the glutamate transporter family. Microbiol Mol Biol Rev 63: 293-307.
19. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, et al. (1994) Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14: 5559-5569.
20. Huang YH, Bergles DE (2004) Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol 14: 346-352.
21. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686.
22. Domercq M, Sanchez-Gomez MV, Areso P, Matute C (1999) Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur J Neurosci 11: 2226-2236.
23. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73-84.
24. Rao VL, Baskaya MK, Dogan A, Rothstein JD, Dempsey RJ (1998) Traumatic brain injury downregulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J Neurochem 70: 2020-2027.
25. Vallejo-Illarramendi A, Domercq M, Perez-Cerda F, Ravid R, Matute C (2006) Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21: 154-164.
26. D'Antoni S, Berretta A, Seminara G, Longone P, Giuffrida-Stella AM (2011) A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death. Neurobiol Dis 42: 252-264.
27. Mitosek-Szewczyk K, Sulkowski G, Stelmasiak Z, Struzyńska L (2008) Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis. Neuroscience 155: 45-52.
28. Sulkowski G, Dąbrowska-Bouta B, Struzyńska L (2013) Modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors. Biomed Res Int 2013: 186068 Available: http://dx. doi:org/10.1155/2013/186068.
29. Sulkowski G, Dą browska-Bouta B, Chalimoniuk M, Struzyńska L (2013) Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis. J Neuroimmunol 261: 67-76.
30. Ohgoh M, Hanada T, Smith T, Hashimoto T, Ueno M, et al. (2002) Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 125: 170-178.
31. Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, et al. (2004) Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 164: 1455-1469.
32. Booth RF, Clark JB (1978) A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain. Biochem J 176: 365-370.
33. Daniels KK, Vickroy TW (1998) Simultaneous isolation of glial and neuronal fractions from rat brain homogenates: comparison of high-affinity L-glutamate transport properties. Neurochem Res 23: 103-113.
34. Sulkowski G, Bubko I, Struzyńska L, Januszewski S, Walski M, et al. (2002) Astrocytic response in the rodent model of global cerebral ischemia and during reperfusion. Exp Toxicol Pathol 54: 31-38.
35. Struzyńska L, Bubko I, Walski M, Rafałowska U (2001) Astroglial reaction during the early phase of acute lead toxicity in the adult rat brain. Toxicology 165: 121-131.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-75.
37. Divac I, Fonnum F, Storm-Mathisen J (1977) High affinity uptake of glutamate in terminals of corticostriatal axons. Nature 266: 377-378.
38. Peng L, Hertz L, Huang R, Sonnewald U, Petersen SB, et al. (1993) Utilization of glutamine and of TCA cycle constituents as precursors for transmitter glutamate and GABA. Dev Neurosci 15: 367-377.
39. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
40. Wang XD, Chen XQ, Yang HH, Hu GY (1999) Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex. Neurosci Lett 272: 21-24.
41. Bolton C, Paul C (1997) MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J Pharmacol Exp Ther 282: 397-402.
42. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies. Neurosci Biobehav Rev 21: 455-468.
43. Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M (2006) Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J Neurosci 23: 2611-2622.
44. Zieminska E, Lazarewicz JW (2006) Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studie in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol Exp 66: 301-309.
45. Sulkowski G, Dabrowska-Bouta B, Kwiatkowska-Patzer B, Struzyńska L (2009) Alterations in glutamate transport and group I metabotropic glutamate receptors in the rat brain during acute phase of experimental autoimmune encephalomyelitis. Folia Neuropathol 47: 329-337.
46. Reynolds IJ, Murphy SN, Miller RJ (1987) 3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc Natl Acad Sci USA 84: 7744-7748.
47. Yuzaki M, Miyawaki A, Akita K, Kudo Y, Ogura A, et al. (1990) Mode of blockade by MK-801 of N-methyl-D-aspartate-induced increase in intracellular Ca2+ in cultured mouse hippocampal neurons. Brain Res 517: 51-56.